Cargando…

Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study

BACKGROUND: Epidemiological measures such as incidence, prevalence, or deaths are essential for monitoring population health. However, evaluating them in isolation cannot adequately compare and assess the relative importance of different diseases. Assessments of the burden of disease (BoD) are there...

Descripción completa

Detalles Bibliográficos
Autores principales: Porst, M, von der Lippe, E, Wengler, A, Leddin, J, Anton, A, Rommel, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593615/
http://dx.doi.org/10.1093/eurpub/ckac129.431
_version_ 1784815205441601536
author Porst, M
von der Lippe, E
Wengler, A
Leddin, J
Anton, A
Rommel, A
author_facet Porst, M
von der Lippe, E
Wengler, A
Leddin, J
Anton, A
Rommel, A
author_sort Porst, M
collection PubMed
description BACKGROUND: Epidemiological measures such as incidence, prevalence, or deaths are essential for monitoring population health. However, evaluating them in isolation cannot adequately compare and assess the relative importance of different diseases. Assessments of the burden of disease (BoD) are therefore of growing importance in supporting health policy decisions. Using disability-adjusted life years (DALY) as a summary measure of population health, BoD integrates morbidity and mortality in a transparent approach. METHODS: Within BoD methodology, deviations in the health of the population from an ‘ideal’ health status is quantified in the unit of life years. DALY are the sum of years of life lost due to death (YLL) and years lived with disability (YLD). While YLL describe the gap between age at death and statistical life expectancy, the indicator YLD quantifies years lived with a disability or disease. Calculations were based on different primary and secondary data sources for Germany, especially cause-of-death statistics, epidemiological survey data, and statutory health insurance data. RESULTS: In Germany, there were about 12 million DALY in 2017, the equivalent of 14,584 DALY per 100,000 population. Coronary heart disease contributes the most to the overall burden of disease, followed by lower back pain and lung cancer. In women, headache disorders and dementias account for more DALY as compared to men. Men have a higher burden of disease from lung cancer or alcohol use disorders. Pain disorders and alcohol use disorders lead the DALY rankings for both sexes in younger adulthood. The burden due to cardiovascular disease, COPD, and diabetes mellitus increases with age and also varies by region. CONCLUSIONS: The results suggest age- and gender-specific prevention as well as regional health care needs. BoD studies therefore provide comprehensive data for population health surveillance and can support health policy decisions. KEY MESSAGES: • The importance of specific diseases as measured by DALY differs greatly by age and gender, highlighting the need for targeted prevention measures. • Regional patterns emerge for cardiovascular disease, COPD, and depressive disorders, among others, which may indicate health care needs.
format Online
Article
Text
id pubmed-9593615
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95936152022-11-22 Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study Porst, M von der Lippe, E Wengler, A Leddin, J Anton, A Rommel, A Eur J Public Health Parallel Programme BACKGROUND: Epidemiological measures such as incidence, prevalence, or deaths are essential for monitoring population health. However, evaluating them in isolation cannot adequately compare and assess the relative importance of different diseases. Assessments of the burden of disease (BoD) are therefore of growing importance in supporting health policy decisions. Using disability-adjusted life years (DALY) as a summary measure of population health, BoD integrates morbidity and mortality in a transparent approach. METHODS: Within BoD methodology, deviations in the health of the population from an ‘ideal’ health status is quantified in the unit of life years. DALY are the sum of years of life lost due to death (YLL) and years lived with disability (YLD). While YLL describe the gap between age at death and statistical life expectancy, the indicator YLD quantifies years lived with a disability or disease. Calculations were based on different primary and secondary data sources for Germany, especially cause-of-death statistics, epidemiological survey data, and statutory health insurance data. RESULTS: In Germany, there were about 12 million DALY in 2017, the equivalent of 14,584 DALY per 100,000 population. Coronary heart disease contributes the most to the overall burden of disease, followed by lower back pain and lung cancer. In women, headache disorders and dementias account for more DALY as compared to men. Men have a higher burden of disease from lung cancer or alcohol use disorders. Pain disorders and alcohol use disorders lead the DALY rankings for both sexes in younger adulthood. The burden due to cardiovascular disease, COPD, and diabetes mellitus increases with age and also varies by region. CONCLUSIONS: The results suggest age- and gender-specific prevention as well as regional health care needs. BoD studies therefore provide comprehensive data for population health surveillance and can support health policy decisions. KEY MESSAGES: • The importance of specific diseases as measured by DALY differs greatly by age and gender, highlighting the need for targeted prevention measures. • Regional patterns emerge for cardiovascular disease, COPD, and depressive disorders, among others, which may indicate health care needs. Oxford University Press 2022-10-25 /pmc/articles/PMC9593615/ http://dx.doi.org/10.1093/eurpub/ckac129.431 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Porst, M
von der Lippe, E
Wengler, A
Leddin, J
Anton, A
Rommel, A
Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title_full Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title_fullStr Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title_full_unstemmed Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title_short Burden of disease assessment for Germany and its regions – results from the BURDEN 2020 study
title_sort burden of disease assessment for germany and its regions – results from the burden 2020 study
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593615/
http://dx.doi.org/10.1093/eurpub/ckac129.431
work_keys_str_mv AT porstm burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study
AT vonderlippee burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study
AT wenglera burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study
AT leddinj burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study
AT antona burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study
AT rommela burdenofdiseaseassessmentforgermanyanditsregionsresultsfromtheburden2020study